Ryan Lucas

Now the decision to do exactly that appears to clear the way for the Senate to move forward

on Warsh's nomination.

Ryan Lucas, NPR News, Washington.

The U.S.

Attorney for Washington, D.C., Jeanine Pirro, says in a statement on X that her office is closing its investigation into Fed Chair Jerome Powell over cost overruns in the renovations of the Fed's headquarters.

Pirro says instead, the Federal Reserve's inspector general has been asked to examine the cost issues.

The Justice Department's investigation into Powell generated major blowback for the Trump administration when the probe's existence became public earlier this year.

It prompted North Carolina Republican Senator Tom Tillis to threaten to block President Trump's pick to replace Powell at the Fed, Kevin Warsh, unless the DOJ dropped its investigation.

Now the decision to do exactly that appears to clear the way for the Senate to move forward on Warsh's nomination.

Ryan Lucas, NPR News, Washington.

The Justice Department says it is immediately rescheduling FDA-approved and state-licensed marijuana from what's known as a Schedule I drug, the same group as heroin, to a Schedule III drug, like Tylenol with codeine.

The move does not legalize marijuana under federal law, but it does recognize that marijuana has medical applications and opens the door to research the effects of cannabis.

The department is also ordering a new hearing to begin in late July to fully reschedule the drug.

The move by the Trump administration comes after years of debate in Washington about reclassifying marijuana.

Ryan Lucas, NPR News, Washington.

The Justice Department says it is immediately rescheduling FDA-approved and state-licensed marijuana from what's known as a Schedule I drug, the same group as heroin.

to a Schedule III drug, like Tylenol with codeine.

The move does not legalize marijuana under federal law, but it does recognize that marijuana has medical applications and opens the door to research the effects of cannabis.

The department is also ordering a new hearing to begin in late July to fully reschedule the drug.

The move by the Trump administration comes after years of debate in Washington about reclassifying marijuana.